Level Bio AB (publ) (NGM:LEVBIO)

Level Bio AB Revenue

Level Bio AB had revenue of 9.00M SEK in the quarter ending March 31, 2026, with 15.20% growth. This brings the company's revenue in the last twelve months to 33.55M, up 22.43% year-over-year. In the year 2025, Level Bio AB had annual revenue of 32.36M with 28.94% growth.

• Revenue (ttm): 33.55M
• Revenue Growth: +22.43%
• P/S Ratio: 0.68
• Revenue / Employee: 3.35M
• Employees: 10
• Market Cap: 22.71M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	32.36M	7.26M	28.94%
Dec 31, 2024	25.10M	-999.39K	-3.83%
Dec 31, 2023	26.10M	-8.24M	-23.99%
Dec 31, 2022	34.33M	-9.63M	-21.90%
Dec 31, 2021	43.96M	20.43M	86.86%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 25, 2026

Data Sources Report a data error